arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CVRx, Inc.

CVRX
$2.71 ▼ -0.17 (-5.90%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
27 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

CVRx, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $71.9M
Dividend Yield —
Revenue Growth 15.6% ↘
Op. Margin -82.9% →
ROIC -16.6% ↘
FCF / Share $-0.34 ↗
Trailing P/E —
Price / Book 3.6x
FCF Yield —
Debt / Equity 2.94
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$15.71M
↑ +15.6% —
Net Income Profit after all expenses
$-14.04M
↑ +4.7% —
Operating Margin Operating profit as % of sales
-82.9%
↓ -0.7% 3th
FCF / Share Free cash flow per share
$-0.34
↑ +27.7% —
Long-Term Debt Long-term obligations
$58.57M
— +0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
3
Returns ↓
6
Financial Health ↑
26
Cash Quality ↑
52

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters